The detection, diagnostic, and monitoring technologies mainly comprise of genomics, proteomics, metabolomics, epigenomic technologies; early detection and diagnosis; personalized medicine; sensor technologies; and patient monitoring systems.
Early Detection and Diagnosis (Non-“Omic” Technologies)
Fast, Portable Genetic Tests
Early Detection CADx
Personalized Medicine and Customizable Devices
Biologically/Drug Customized Tx
Patient Monitoring Systems
Remote Monitoring (e.g. Home, Implanted, Portable, Wireless)
Among the detection, diagnostic, and monitoring technologies, the highest likelihood for innovation and new product development is predicted for the sensor technologies including a wide range of advanced sensors; patient monitoring systems (e.g. remote monitoring systems); and genomic, proteomic, metabolomic, and epigenomic technologies (e.g. genetic diagnostic products). Computer-assisted diagnostics could be considered as one of the upcoming technologies for innovative products. The primary constraints include liability concerns related to false-negative findings, and concerns about the availability of realistic therapies for diagnosis during the next five year forecast period.